Zhejiang Haizhou Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHOCARBAMOL (PROCESS ISOPROPANOL), with a corresponding US DMF Number 37436.
Remarkably, this DMF maintains an Active status since its submission on February 23, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 22, 2023, and payment made on March 08, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II